ロード中...

Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin

Antibodies have created high expectations for effective yet tolerated therapeutics in acute myeloid leukemia (AML). Hitherto the most exploited target is CD33, a myeloid differentiation antigen found on AML blasts in most patients and, perhaps, leukemic stem cells in some. Treatment efforts have foc...

詳細記述

保存先:
書誌詳細
主要な著者: Cowan, Andrew J., Laszlo, George S., Estey, Elihu H., Walter, Roland B.
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3683663/
https://ncbi.nlm.nih.gov/pubmed/23747885
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!